Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00216-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanmic&utm_campaign=update-lanmic&utm_medium=email&_hsmi=274133915&_hsenc=p2ANqtz-9QVuOEY4rzX25SzDgHVgg8wiC7HZ_wg9ZReqM848YxyeZ682lO0RfR5uKhkFVa6lsb-BxWv2l0EDOfUqwnRCh8JShcaQ&utm_content=273912895&utm_source=hs_email